In partnership with TEC Edmonton, BioAlberta celebrates ... Documents/HLSS pro… · Ocular...
Transcript of In partnership with TEC Edmonton, BioAlberta celebrates ... Documents/HLSS pro… · Ocular...
In partnership with TEC Edmonton,
BioAlberta celebrates our
19th annual AGM and Awards Gala
with the Health and Life Sciences Showcase
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
BioAlberta’s signature event is a gathering
of key industry stakeholders.
We will honour the
founders, researchers and entrepreneurs
of Alberta’s Life Sciences Industry.
#BioAlbertaShowcaseAwards2018
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
AGM, SHOWCASE & GALA AGENDA
9:00 – 10:15 BioAlberta Board Meeting – QUARTERHORSE A
10:30– 11:30 BioAlberta AGM – PALOMINO A
1:00 – 1:25 Opening Remarks – PALOMINO D&E
1:30 – 4:30 Investment Pitches, Industry Roundtables and One-on-One Partnering (details below)
4:00 – 6:00 Table Displays - LOBBY
5:00 – 6:00 Networking and Reception - LOBBY
6:00 – 9:00 Gala Dinner and Awards Presentations – PALOMINO D & E
INVESTMENT PITCHES & INDUSTRY ROUNDTABLES
TIME PALOMINO A PALOMINO B PALOMINO C
1:30 – 2:45 Investment Pitch
Health IT & Med Tech
Roundtable
Natural Health Products One-on-one Partnering
2:45 – 3:00 Break Break Break
3:00 – 4:30 Investment Pitch
Health IT & Med Tech
Roundtable
Institute of Health Economics One-on-one Partnering
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
MORNING AGENDA
BioAlberta Board Meeting 9:00 – 10:15 AM
BioAlberta Annual General Meeting 10:30 – 11:30 AM
AFTERNOON AGENDA
Opening Remarks 1:00 – 1:30 PM
Afternoon Sessions 1:30 – 4:30 PM
Life Sciences Pitch Sessions
Companies in health IT and medical technology sectors pitch to a panel and audience of investors. Companies
have 10 minutes to pitch and five minute Q&A by panel and facilitator. This will be broken into two sessions.
Facilitator: Greg Klak, General Manager, Gilead Alberta ULC and BioAlberta Board Member
COMPANIES PITCHING:
1. Clinisys EMR Inc.
2. Elsius Biomedical Corporation
3. MagnetTx Oncology Solutions
4. Metabolomics Technology Inc.
5. Neuraura Biotech
6. SafeTracks GPS Canada Inc.
7. Salu Design Group Inc.
8. Think Tank Innovations (ShareSmart)
9. Tevosol
10. Zenxmed Innovations Inc.
CONFIRMED INVESTORS:
1. Acuris Partners
2. Accel-Rx
3. ATB Financial
4. Brass Dome Ventures
5. Builders VC
6. Connection Silicon Valley
7. Flagship Pioneering
8. GE Healthcare
9. Greybird Ventures
10. Kensington Capital
11. NeuroCrunch
12. Radiant Health Advisors
13. RBC
ANGEL INVESTORS:
1. Hatim Chraibi
2. Konstatin Kostov
3. Larry Miller
4. Ziad Moukheiber
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
I N V E S T O R S
Accel-Rx
Michael Lincoln, Chief Financial and Business Officer, Accel-Rx currently serves as
Chief Financial and Business Officer at Accel-Rx Health Sciences Accelerator. He has
over twenty-five years of senior management experience in the biotechnology and
pharmaceutical industry from start-ups to multi-national pharmaceutical companies.
Michael has extensive experience in finance and business development and has a track
record of supporting the growth of small and medium size businesses through all stages
of development. Previous experience includes public and private equity financing, IPO,
investor relations, licensing of technology, M&A activity, joint ventures, and the
licensing of numerous branded products.
Prior to joining Accel-Rx, Michael was the Chief Financial and Business Officer at CDRD Ventures Inc., Chief
Financial Officer & Senior Vice President at MedGenesis Therapeutix Inc., Vice-President of Business
Development at Transition Therapeutics Inc. and has held various management positions at Altimed
Pharmaceuticals and Merck Frosst Canada.
Mr. Lincoln earned his Master of Business Administration degree, and a Bachelor’s degree in Economics from
Concordia University, Montreal, QC, and is a Chartered Professional Accountant (CMA).
Acuris Partners
Samuel Wu has been a healthcare venture capital investor since 2002. He is a
founding partner at Acuris, which was recently launched by the MedImmune
Ventures team out of AstraZeneca. Previously he was the managing director of
MedImmune Ventures’ West Coast office from 2010 to 2016, and a principal at SV
Life Sciences, where he invested in a broad range of biopharmaceutical, platform
and medical device companies. Sam is or has been a board member of Applied
Genetic Technologies Corp (NASDAQ:AGTC), Cerapedics, Hydra Biosciences,
Ocular Therapeutix (NASDAQ:OCUL), and the California Life Sciences Institute.
Prior to his VC career, he was an Engagement Manager with McKinsey and Company, leading teams of
consultants serving life science clients on M&A, portfolio analysis and other strategic issues.
Sam holds a B.A. magna cum laude in Biochemistry from Harvard University, attended Stanford University
School of Medicine where he earned an M.D. and a Ph.D. in Biochemistry as a Howard Hughes Fellow, and
trained in Internal Medicine at the University of California, Los Angeles.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
ATB Financial
Sasha Musij - A passion for pioneering growth in Alberta’s constantly evolving
agricultural landscape plays a key role in Sasha’s approach to building the most
effective financial solutions for ATB’s agribusiness clients, tailored to their specific
needs. This includes everything from pre-farm sciences and technologies through to
post farm gate production, manufacturing and innovation. His support extends to
being a thought leader, connecter, catalyst and lender to the agribusiness ecosystem
throughout Alberta.
Prior to joining ATB, Sasha worked with Calgary Economic Development as the Business Development
Manager for Agribusiness. He designed and implemented their Agribusiness strategy under the 10-year
Economic Strategy, which had a mandate to support the city's diversified sectors. The primary focus of this
role was designed around the development of a business enabling ecosystem that would strengthen investment
attraction, expansion opportunities and overall policy. Within this role Sasha worked with the full value chain
of Agribusiness from large corporations to SME’s and startups involved in pre-farm sciences/inputs,
agritechnologies, professional and financial services and food and beverage manufacturing.
Business is personal, and creating strong relationships is critical to providing the right service. “The more
you understand operational needs and motivations, the better you can align them with offerings to serve them
best,” Sasha says. “My goal is to find out what’s best for the client and move forward with the right solution
to achieve the desired results, now and well into the future.”
An avid outdoor enthusiast, Sasha’s passion for the agribusiness sector stems from his love for the outdoors,
discovering where our food comes from and exploring innovations that provide us sustainable solutions.
Whether its spending time in the mountains or driving through the prairies, his curiosity for the natural
ecosystem has driven his interest in supporting the full agribusiness value chain.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Brass Dome Ventures
Christopher Micetich – Founder, President & CEO of Brass Dome Ventures
Ltd., a business to business consultation company offering assistance to many
companies across many industries. The company employs a proven team of
administrative experts with a long track record of success specializing in a wide
variety of business areas. Chris is also Founder, President & CEO of Fedora
Pharmaceuticals Inc., a pharmaceutical drug discovery company specialized in
the area of infectious diseases. In December 2012, Fedora signed the largest
licensing deal ever signed in Canadian biotech history licensing their beta-
lactamse inhibitor discovery program to Hoffman J. La Roche for milestone
payments of US$750,000 in addition to double digit royalties. Chris was also
Founder, President & CEO of numerous companies including:
Naeja Pharmaceuticals Inc., was a contract drug discovery company offering chemistry and biology services to
over 100 companies around the world. Naeja was, for many years, the largest employer of PhD’s in Canada
employing 130 full time employees. . Naeja employees were contributors to +500 patents and publications in
numerous areas of research.
DrisCorp Inc.was a drug discovery company offering chemistry research services to the pharmaceutical
industry. DrisCorp employed over 35 PhD chemists offering chemistry services to several large pharmaceutical
companies around the globe. The creation of Naeja led to the rolling over of DrisCorp’s contracts and
employees before the eventual acquisition of the company by Brass Dome Group Inc.
Windjammer Java Roasters Inc. was a specialty gourmet coffee roasting company offering both retail and
wholesale coffee beans to consumers. Raw green coffee beans from around the globe were imported, roasted
and sold. Windjammer’s niche was dating the roasted coffee and donating any coffee beyond two weeks from
the date of roasting to homeless people through the Mustard Seed Church. The company assets were eventually
sold before rolling Windjammer into Brass Dome Group Inc.
Chris was also COO of SynPhar Laboratories Inc. a joint venture company created between Ronald G. Micetich,
Canada and Taiho Pharmaceutical Company Ltd., Japan. The joint venture was the first ever signed between a
Canadian individual and a Japanese company. Christopher joined the company at inception and contributed to
the growth from 4 to 65 employees. SynPhar was responsible for +120 compositional matter patents in
numerous areas of research and boasts two drugs on the market today along with numerous still in development.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Builders VC
Jim Kim, General Partner, is a founding member and GP of Builders VC.
Prior to Builders, Jim founded Formation 8 and served as its Managing
Partner. Jim enjoys investing in entrepreneurs working on transformative,
contrarian companies. He currently serves on the boards of IT and
Diversified Technology companies including: Context Relevant, EVA,
Bolt Threads Taxon Biosciences (sold to DuPont), and GrabIt, and
previously served on the boards of Wish and Lucid Design.
Prior to Formation 8, Jim was a General Partner at Khosla Ventures, where
he led investments and founded technology companies in a variety of
industries including IT, hardware, energy, and consumer products. Prior to
KV, Jim joined CMEA Capital as a Senior Partner in their E M practice.
Jim began his career with GE Capital’s Structured Finance group where he worked on a variety of IT Telecom
financings before joining the Energy Finance team and working to grow their portfolio to $15B in assets. At
GE, Jim also co-founded the GE Ventures initiative and led investments in China High Speed Transmission,
ComScore, A123 Systems, Danger, and several later-stage companies across diverse technology sectors.
Jim received undergraduate degrees in Computer Science Electrical Engineering and Political Science from
MIT, where he also founded a venture-backed Internet infrastructure start-up with fellow Course 6 students.
He also holds a Masters Degree in Quantitative Data Analysis from Columbia University and an MBA from
Columbia Business School.
Jim enjoys kung-fu, tai chi, making wine (DJK Lei), and fishing, and he hopes to see the U.S. Soccer team
win a World Cup in his lifetime.
Connection Silicon Valley
Joanne Fedeyko is the founder and CEO of Connection Silicon Valley (CSV),
an organization that helps companies collaborate, connect, innovate, and
partner with Silicon Valley's world-renowned technology ecosystem. Their
business is centered around bringing better innovation to Canada by helping
startups and large corporates leverage the best of innovation from Silicon
Valley. Joanne is a Founding Board Member of Canadian Entrepreneurs in Life
Sciences (CELS) --- a nonprofit organization supporting the advancement of
Canadian life science technology businesses by access to connections,
community and capital in the San Francisco Bay Area.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Flagship
Pioneering
Avak Kahvejian joined Flagship Pioneering in 2011, focusing on internal
biotechnology innovation and venture creation. Avak was on the founding teams
of Seres Therapeutics and Codiak BioSciences, and he is a co-founder of Rubius
Therapeutics. Currently, Avak serves as founding president and CEO of Cygnal
Therapeutics, a company pioneering the field of exoneural biology for the
treatment of cancer, autoimmunity and other diseases.
Prior to Flagship, Avak was at Helicos BioSciences, a Flagship VentureLabs
company which developed and commercialized the world’s first single molecule
sequencing technology.
At Helicos since 2004, Avak held various business development, product management, marketing and sales
roles. Most recently, as vice president, business development for Helicos, he focused on establishing strategic
partnerships in the areas of high-throughput sequencing and molecular diagnostics, leveraging the technology’s
unique capabilities.
Avak earned his Ph.D. from McGill University in the laboratory of Dr. Nahum Sonenberg, where his research
focused on modulators of mRNA translation and their regulation. During his studies at McGill, Avak was
awarded a Canadian Institutes of Health Research operating grant as a co-investigator to Dr. Sonenberg, and
was selected for the Dean’s Honor List upon graduation.
As a member of the Board of Directors for Canadian Entrepreneurs in New England (CENE), Avak has
reviewed, selected, and mentored numerous promising Canadian startups to help them tap into Boston's
innovation ecosystem. CENE is a nonprofit, member-driven organization dedicated to empowering Canadians
to grow successful businesses globally.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
GE Healthcare
•
Dr. Dan Zikovitz, Principal Solutions Architect – is currently a Principal
Digital Solutions Architect at GE Healthcare Canada with national
responsibility working with customers to achieve meaningful outcomes
through Big Data and Analytics. With over 20 years of Healthcare experience
coupled with extensive experience in data and analytics and software
development, his approach has been used to solve challenges that hospitals are
facing around the world.
He serves as a Digital Ambassador for GE Healthcare Canada supporting several businesses across Canada
providing customer support as well as a conduit into GE-Digital international.
Daniel holds advanced degrees in Biology and Computer Science from York University’s Centre for Vision
Research developing computer models of how the human brain perceives self-motion through several senses
modelled as sensors. He has held teaching appointments in the faculties of Biology, Psychology and Computer
Science. A Certified Modeling and Simulation Professional, he has delivered over fifty articles and platform
presentations
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Greybird Ventures
Tom Miller, after receiving a degree in Nuclear Engineering from the University
of Massachusetts at Lowell, studied Medical Physics at the Harvard/MIT Health
Sciences and Technology joint program graduating with a Masters degree in
1982. During his academic career he worked at Los Alamos, the Swiss Institute
for Nuclear Research (now the Paul Scherer Institute), Brookhaven National
Laboratory, and the Massachusetts General Hospital as a research associate in
radiation biophysics.
Tom then joined Siemens Medical Systems where, after 9 years, he became the
first non-German CEO of a German factory and business unit. He left Siemens
after 15 years to become CEO of the global medical operations of Carl Zeiss.
Completing a successful turnaround, he joined Analogic Corporation as CEO. After three years and a doubling
of the stock price, Tom left to become CEO of LightLab Imaging, a start-up that he helped to establish.
Completing a profitable sale of LightLab to a Japanese company, Tom re-joined Siemens eventually serving as
a member of the operating board of Siemens Healthcare and the CEO of the Customer Solutions Division,
responsible for 26,000 employees in over 130 countries.
In 2013, Tom started GreyBird Ventures, an investment firm focused on emerging technologies for precision
medicine diagnosis. He currently serves as board chairman or independent director on the boards of five medical
technology companies.
Tom is a frequent speaker on healthcare technology and business at such venues as the National Press Club, the
National Library of Medicine, the National Institute of Health, and the American Hospital Association. He was
selected by the diagnostic imaging industry to provide Congressional testimony to the House Health Sub-
Committee in June of 2009 and to speak on breast cancer technology at the European Parliament in 2012.
Sponsored by the American Hospital Association, Tom gave the keynote at the Health Executive Forum in
Arizona in 2013 on sustainable healthcare and Precision Medicine and authored an article for Arab Health
Magazine summarizing a keynote speech given at the 2013 Arab Health meeting in Dubai on the same topic.
Tom’s international reputation gave him the honor of giving the 2013 commencement address at the India
Institute of Technology in Roorkee, and keynote addresses to the Chinese Private Hospital Association in 2014
in Wuhan, the Innovation for Health Conference in 2015 in Amsterdam, the 2015 TiE Leapfrog Conference in
Bangalore, the 2016 World Executive Healthcare Forum in Montreal, and in 2017 he both organized and spoke
at the first Precision Medicine in Oncology Conference in Tianjin China as well as the Harvard Personalized
Medicine Conference.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Kensington Capital
Dylan Freeze is an Analyst on Kensington’s venture capital investment team,
based in Vancouver.
Dylan’s career began as an Analyst at iData Research, a Vancouver Based
Market Research firm focused on the medical sector. Dylan transitioned to a role
as a Program Manager at the BC Tech Association in 2015 and quickly
immersed himself in Vancouver’s rapidly growing tech ecosystem.
He managed a program called HyperGrowth:Life which selected promising
companies and put together a year of programming and advisory board to help
accelerate their businesses
Dylan also managed BC Tech’s Connection Day program connecting out of province/country investors and
corporate partners to local technology companies. Dylan’s main areas of focus at BC Tech were
HealthTech/Life Sciences, Cleantech, and Industrial Technology.
Dylan holds a B.Sc. in Biology from the University of Victoria.
NeuroCrunch
Tim Owen is CEO of NeuroCrunch and Board President, Canadian Entrepreneurs in
New England (CENE). Tim has more than 25 years of experience in the high tech
industry. He has been a pioneer in the cloud-based software market and has held key
roles with numerous start-ups, including 3 that were acquired by larger
companies. Tim is currently the founder and CEO of NeuroCrunch, a technology
ventures company. Previously he held the role of SVP, Global Sales for rFactr, a
social selling company.
Tim thrives on helping start-up companies build high-performance sales teams and processes, early-stage
account development, grow indirect sales channels and forge strategic partnerships.
Tim is also President, Board Director, and Founding Member of The Canadian Entrepreneurs in New England
(CENE). CENE's Boston-based members share their expertise with fellow Canadians through mentorship,
investment strategy, networking and thought leadership programs. He is passionate about helping Canadian
start-ups achieve their full business potential in New England and across the US.
Tim has strong Western Canada roots. He graduated from the University of Saskatchewan and lived in Calgary
for 13 years prior to moving to Boston.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Radiant Health Advisors
Kaushik Srinivasan is an accomplished C-Suite Executive, Consultant,
Healthcare Attorney, Medical Real Estate Developer, and Entrepreneur with
substantial success in the healthcare industry spanning clinical services,
outpatient and ancillary care, medical devices, health law, and commercial real
estate.
Throughout his executive career, Kaushik has held leadership positions with
increasing responsibility in a variety of healthcare roles. As a CEO in training
at Community Health Systems and Quorum Health, he has overseen the
operations and growth of several clinical and ancillary departments, introduced
new service lines for Orthopedics and Wound Care, led the construction of
outpatient clinics, and identified opportunities to innovate by partnering with
third-party vendors.
As the President and Managing Partner of Radiant Health Advisors, he has led due diligence analyses and
business plan developments for Fortune 500 companies, medical schools, and top universities. In addition, he
has provided legal and business consulting to various clients pertaining to mergers & acquisitions, medical
device commercialization, contract negotiations, financial valuations, and regulatory approval. In addition, he
has provided legal and business consulting to various clients pertaining to mergers & acquisitions, medical
device commercialization, contract negotiations, and financial valuations. Kaushik is licensed as an attorney in
several state and federal jurisdictions in the United States, and has leveraged his experience in health law and
regulation to be a valuable asset for startup to mid-size growth-stage companies navigating the healthcare
regulatory environment.
RBC
Stephen Donovan is a Commercial Account Manager with RBC supporting
energy and technology companies in Calgary, AB. Stephen has been with RBC
for 2 years, and prior to joining RBC spent time working in the energy and
manufacturing industries. Stephen is from Newfoundland, and is currently
completing his MBA at the University of Calgary with specializations in
finance and entrepreneurship & innovation.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
A N G E L I N V E S T O R S
Hatim Chraibi is co-founder and managing director-USA at SPIRE Bioventures. With
more than 18 years experience in the medical device industry in both upstream and
downstream capacities globally, Hatim received a bachelor degree in Finance from the
University of San Francisco, and an MBA from McGill University (Exchange program
at the Luigi Bocconi University in Milan, Italy).
Before co-founding SPIRE Bioventures where he acts as Managing Director USA. SPIRE
Bioventures, is a Palo Alto and Barcelona based heath science accelerator that aims to
boost early concepts in the vibrant Canadian and European ecosystems.
Hatim has had tenures at Philips Medical Systems, Covidien and other smaller medical device companies. He
has worked on product requirements with R&D teams and key opinion leaders worldwide and built various
global organizations and contributed significantly to their international visibility and sales. Hatim has an
intimate expertise of the Medical device industry worldwide, has worked in various countries and is fluent in 5
languages.
His areas of interest and expertise include start-up mentoring in product definition/positioning, market research,
key opinion leaders’ engagement, product positioning and global distribution. Hatim is also a strategic advisor
for Typlit, a tubular ligation device in Laparoscopic procedures and DNAmito, a MtDNA diagnostic company
in precision medicine for cancer treatment. Hatim is also a mentor with the French Tech Hub in San Francisco,
CA and part of the founding team of CELS (Canadian Entrepreneurs in Life Sciences).
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Larry Miller of BlueTree Allied Angels is a group of accredited investors that invests in regional, early-stage
companies. Our members-only organization operates as a network of private equity investors that meets
monthly to evaluate and consider pre-institutional investments.
Leveraging our members’ knowledge and experience helps to mitigate investment risk, thus, strengthening the
probability of investment success. Although the membership works together as a group to efficiently and
effectively evaluate investment opportunities, each member makes his or her own individual investment
decisions. In addition to our angel network, we are pleased to announce the creation of the BlueTree Venture
Fund. The Fund is a passive investment vehicle designed to allow investors to invest their capital without
investing their time.
Larry Miller, Chairman of Life Science Deal Flow Committee
As Chairman of the Life Science Deal Flow Committee, Larry leverages his strong network and background
to actively seek out promising deals and guide BlueTree’s deal screening process for all life science
companies. In addition to his work at BlueTree, Larry serves as an Executive in Residence at Innovation
Works.
As an Executive in Residence, Larry Miller works with the management teams of early stage life science or
medical device start-up technology companies. The goal is to assist the entrepreneurial community to identify
and address their critical business issues including intellectual property creation and protection, product
development, marketing, sales, fundraising, management recruitment and growth planning. For portfolio
companies, Larry provides mentoring and network access, and may serve as an observer on the Board of
Directors.
Larry has broad experience in medical device and capital equipment marketing, sales service and equipment
finance including 16 years of P&L and balance sheet management of divisions as large as $600M in sales to
as small as a skunk works product development team designing novel permanent magnet based MRI systems.
Prior to joining Innovation Works, Larry was President and CEO of Biomec, a technology accelerator and
investment company which raised over $20M in SBIR grants, and provided business development consulting
for a number of radiology product manufacturers and distributors. At Picker International and Philips Medical
systems, Larry was president of the Healthcare Products group, a $600M distributor of radiology supplies,
managed the Asia/ Pacific region for sales and service of the diagnostic imaging product portfolio, and was
president of the Picker Financial Group, a JV, captive leasing company. Other assignments include marketing
and sales of CT and MRI products for Picker and General Electric Medical Systems.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Ziad Moukheiber, Boston Harbor Angels: Angel and early stage investing in technology and life sciences
companies. M.A.I.B. _ Mentor, Advisor, Investor, Board-member.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of our assets in
high-growth, early-stage companies. Since 2004, our portfolio has included companies in information
technology, life sciences, consumer products, business products, services, specialty materials, aviation and
more. We believe we contribute more than just money to the companies we fund. We welcome the opportunity
to work with entrepreneurs who are open to taking advice, yet have the smarts and determination to make their
company successful.
Our focus is early-stage companies that are looking to raise $250K to $1.5M. We look for companies where
we can fund a portion of the round and syndicate the deal with other angel groups or early-stage venture funds.
The company should be close to the commercialization stage and have a clear and defensible competitive
advantage. We are looking for capital-efficient businesses that can reach profitability with less than $5M of
equity investment and provide at least a tenfold return on the investment within five years.
Boston Harbor Angels does not invest as a fund—each of our members makes his or her individual investment
decision. Members collaborate in due diligence. We are open to any opportunities that can make a strong
business case and can take the position of a lead investor if one of us has strong expertise within our group.
We are proud partners with Nutter McClennen & Fish LLP, MPR Product Development, The Bulfinch Group
and Babson College.
Boston Harbor Angels was founded in February 2004 by Mic Williams. Day-to-day operations are managed
by Ziad Moukheiber.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
INDUSTRY SPECIFIC ROUNDTABLES 1:30 – 4:30 PM
Aim of all roundtables will be for BioAlberta to take the next steps forward in advocacy for policy development.
ROUNDTABLE 1:30 – 2:45 PM
NATURAL HEALTH PRODUCTS AND FUNCTIONAL INGREDIENTS “BRANDING THROUGH COLLABORATION”
Having an Alberta Natural Health Products Brand serves to differentiate products in the marketplace, and it
attracts and retains loyal customers. Beginning efforts could include cataloguing, participating in the
Compendium of Pharmaceuticals and Specialties (CPS), showcasing and more. Discussion at the roundtable
should involve everyone that has an interesting in Markets and Public Engagement for Natural Health Products
and Functional Ingredients.
Facilitator: Steve Jakeway Ph.D.
Steve joined Radient Technologies Inc. as the
Director, Sales and Marketing in 2017. He has
worked in business development for more than 10 years holding senior
management roles in several technology-based companies including
GrainFrac and BioNeutra. He also assisted the University of Alberta,
Department of Oncology to develop a commercialization plan for their
medical cyclotron. He has been a key account manager into many of the
world’s largest market leading companies including Intel, PepsiCo, General
Electric, Nestle, Intel, General Mills, Phillips, Roquette, and The Coca Cola
Company.
Steve has assisted many start-up companies providing assistance for operations, business development,
technical, and finance (raising almost $27M).
Steve received a Ph.D. in Analytical Chemistry (2002) from the Imperial College, University of London
(UK) where he developed a reusable microfluidic device to identify multiple different DNA stands. His
M.Sc. in Chemistry (1999) from the University of Toronto focused on the development of fiber-optic DNA
probe. In obtaining his B.Sc. in Chemistry (1996) from the University of Alberta he participated in research
on implantable electrodes for glucose monitoring as part of the larger program that led to the development
of the world-renowned Edmonton Protocol for islet transplant. Steve also serves on the board of directors
for Agriculture and Food Council (Vice-Chair) and the Association of the Chemical Professional of Alberta.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
ROUNDTABLE 3:00 – 4:30 PM
INSTITUTE OF HEALTH ECONOMICS “SME EDUCATION SERIES ROUNDTABLE”
Beginning in late Fall 2018, the IHE will be providing a four-part education series for Alberta life sciences SMEs
and ecosystem partners to ensure understanding of the importance of, and requirements for, economic evaluation
to support product and business planning. Early stage companies can benefit from health economics by
understanding the 'innovation headroom' available and the commercial viability of their product, which can be
used to guide R&D focus and support capital raises. Later stage organizations can benefit from health economics
by robust documentation of their value proposition to prepare a complete and compelling evidence package
(clinical and economic) in support of procurement efforts. This Roundtable will provide an overview of the series,
and enable participants to help define the content of the series so it is most valuable to them. www.ihe.ca
Facilitator: Keith Gilchrist, Government Affairs and Market Access, Janssen Inc. and
BioAlberta Board Member
MODERATOR: Dan Palfrey, BSc. MPH
Dan Palfrey is a senior consultant working with the Institute of Health
Economics. In previous roles Dan has held progressive leadership positions with a
multinational pharmaceutical organization in Market Research, Sales, Marketing,
Product Management and Government Relations, and most recently was a Vice
President with one of Canada's leading Electronic Medical Record (EMR)
companies. Dan has Master of Public Health and Bachelor of Science degrees from the
University of Alberta and is a past recipient of the Robert Wood Johnson Award.
PRESENTER: Dr. Gareth Hopkin
Dr. Gareth Hopkin is a Research Fellow at the IHE. He obtained his PhD in Health
Services Research at King’s College London, and also holds a BSc (Hons) in Applied
Psychology from Cardiff University. Prior to joining the IHE, Gareth was a Fellow in
Health Policy at the London School of Economics, where he taught on executive and
full-time MSc courses (including economic evaluation, research design for health
policy, and measuring health system performance), alongside conducting health
services research and economic evaluations in several health areas. He has particular
interests in the impact and cost-effectiveness of health policies and complex
interventions and the health of disadvantaged and underserved populations.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
ONE-ON-ONE PARTNERING 1:30 – 4:15 PM
The One on One Partnering stream will be run in a “speed-dating” format. Multinationals (MNEs) and Venture
Capitalists (VCs) will be matched with SMEs and potentially some researchers based on the multinationals’ and
VCs’ primary areas of focus. MNE and VC representatives will be seated at separated tables and SME executives
and researchers will come to them to make short, 15-minute presentations on their lead product or discovery.
Facilitator: Sharon Barker, Director, TEC Edmonton Health Accelerator
NETWORKING 4:00 - 6:00PM
Immediately following the afternoon sessions is the Vendor Showcase and Gala Reception for casual networking.
Those wishing to showcase their services or collaborations, will be able to do so around the reception area:
Vendor Showcase
Participating companies:
BioTalent Canada
Bay Area Research Laboratories
Hicks & Associates Intellectual Property
Mitacs
SafeTracks GPS Canada Inc.
NETWORKING RECEPTION 5:00-6:00PM
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
BioAlberta ’s 1 9 t h Annual Awards Gala 6 :0 0 - 9 :0 0 p m
Our annual gala is held to network and celebrate outstanding achievements within the industry. This premier
event brings together the membership and friends of the industry to honour achievement and celebrate the
industry’s milestones. It is always an enjoyable and memorable evening, and the successes in our industry are
acknowledged by presenting awards for: "Company of the Year" and "Scientific Achievement and
Innovation".
KEYNOTE: Jason Pincock, CEO, DynaLIFE Medical Labs and Chair, Edmonton Health City
Jason is currently the Chief Executive Officer of DynaLIFE Medical Labs, one of
Alberta’s largest private healthcare organizations. At over 1100 employees DynaLIFE
is Canada’s most regarded multidisciplinary clinical laboratory organization and is
recognized as one of Canada’s Best Managed Companies. DynaLIFE provides clinical
diagnostics to support physicians, patients, hospitals and other health providers from
central Alberta through the Territories. DynaLIFE is internationally accredited for
quality and is routinely listed as one of Albert’s Best Workplaces.
Its dedication to the community includes sponsorships and fundraising for a variety of
charities as well as support for researchers and health care start-up organizations.
Jason is a Certified Management Accountant, a graduate of the Queens Executive Program and a member of
the Institute of Corporate Directors. Jason works with an ownership board, including OMERS and Laboratory
Corporation of America (publicly traded. With a decade of experience at the executive level his background
includes roles from CFO to Government Relations. Although his professional background is financial, he is
regarded for his transparent and accountable leadership style, as a creator and driver of innovation and strategy.
Jason participates in various bio‐tech related industry groups, works with Economic Development and
participates on various community committees. Jason is currently the Vice Chair of Edmonton’s Health City
initiative and is serving on the boards of Little Warriors, Bissell Centre, and Viewics a US health analytics
company. On a personal level, Jason lives in St. Albert with a big family that includes six active children. In
between work and kids he is an active outdoorsman with passions from sailing to skiing, motorbikes to
mountains, and loves to spend time with his family in the back country or behind the boat at their cabin.
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
G A L A P RO G R A M Master of Ceremonies
Ms. Bridgette Duniece, VP External Affairs and Operations, Permolex Ltd. & BioAlberta Board Member
6:00 PM Welcome
6:15 PM Remarks by Government Representative
6:20 PM Dinner Service Begins
6:30 PM Announcements
*Continuation of Dinner Service*
7:20 PM Keynote Address by Jason Pincock
7:55 PM Awards Presentations Commence
Award for Company of the Year
Award for Scientific Achievement and Innovation
8:30 PM Special Recognition
8:40 PM Closing Remarks
MENU Southwestern Tortilla Salad
West Coast Grilled AAA Alberta Strip Loin Steak
Western Potato Wedge
Fresh Seasonal Vegetables
Tres Leche Flan with Seasonal berries
Cono Sur Bicicleta Sauvignon Blanc (Colchagua, Chile)
Cono Sur Bicicleta Merlot (Maule Valley, Chile)
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
Thank You to Our Sponsors
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
N O T E S
Monday 24 September 2018
BMO Centre, Stampede Park, Calgary
#BioAlbertaShowcaseAwards2018
With special thanks to our partners, sponsors and guests
drive safely
Please join us next year as BioAlberta celebrates our 20th
year!
1999 - 2019